BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 25228314)

  • 1. Porphyromonas gingivalis gingipains selectively reduce CD14 expression, leading to macrophage hyporesponsiveness to bacterial infection.
    Wilensky A; Tzach-Nahman R; Potempa J; Shapira L; Nussbaum G
    J Innate Immun; 2015; 7(2):127-135. PubMed ID: 25228314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of gingipains in the pathogenesis of periodontal disease.
    Imamura T
    J Periodontol; 2003 Jan; 74(1):111-8. PubMed ID: 12593605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteolysis of human monocyte CD14 by cysteine proteinases (gingipains) from Porphyromonas gingivalis leading to lipopolysaccharide hyporesponsiveness.
    Sugawara S; Nemoto E; Tada H; Miyake K; Imamura T; Takada H
    J Immunol; 2000 Jul; 165(1):411-8. PubMed ID: 10861079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of lipopolysaccharide receptor CD14 from the surface of human macrophage-like cells mediated by Porphyromonas gingivalis outer membrane vesicles.
    Duncan L; Yoshioka M; Chandad F; Grenier D
    Microb Pathog; 2004 Jun; 36(6):319-25. PubMed ID: 15120158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gingipains inactivate a cell surface ligand on Porphyromonas gingivalis that induces TLR2-and TLR4-independent signaling.
    Kishimoto M; Yoshimura A; Naito M; Okamoto K; Yamamoto K; Golenbock DT; Hara Y; Nakayama K
    Microbiol Immunol; 2006; 50(4):315-25. PubMed ID: 16625053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gingipain-dependent augmentation by Porphyromonas gingivalis of phagocytosis of Tannerella forsythia.
    Jung YJ; Jun HK; Choi BK
    Mol Oral Microbiol; 2016 Dec; 31(6):457-471. PubMed ID: 26434368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Porphyromonas gingivalis gingipains cause defective macrophage migration towards apoptotic cells and inhibit phagocytosis of primary apoptotic neutrophils.
    Castro SA; Collighan R; Lambert PA; Dias IH; Chauhan P; Bland CE; Milic I; Milward MR; Cooper PR; Devitt A
    Cell Death Dis; 2017 Mar; 8(3):e2644. PubMed ID: 28252646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of RgpA in the pathogenicity of Porphyromonas gingivalis in the murine periodontitis model.
    Wilensky A; Polak D; Houri-Haddad Y; Shapira L
    J Clin Periodontol; 2013 Oct; 40(10):924-32. PubMed ID: 23909600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gingipains as candidate antigens for Porphyromonas gingivalis vaccine.
    Nakagawa T; Saito A; Hosaka Y; Ishihara K
    Keio J Med; 2003 Sep; 52(3):158-62. PubMed ID: 14529148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Porphyromonas gingivalis selectively up-regulates the HIV-1 coreceptor CCR5 in oral keratinocytes.
    Giacaman RA; Nobbs AH; Ross KF; Herzberg MC
    J Immunol; 2007 Aug; 179(4):2542-50. PubMed ID: 17675516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody responses to Porphyromonas gingivalis infection in a murine abscess model--involvement of gingipains and responses to re-infection.
    Yoneda M; Hirofuji T; Motooka N; Anan H; Hamachi T; Miura M; Ishihara Y; Maeda K
    J Periodontal Res; 2003 Dec; 38(6):551-6. PubMed ID: 14632916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response of macrophages induced by Porphyromonas gingivalis requires HmuY protein.
    Gmiterek A; Kłopot A; Wójtowicz H; Trindade SC; Olczak M; Olczak T
    Immunobiology; 2016 Dec; 221(12):1382-1394. PubMed ID: 27473343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Porphyromonas gingivalis gingipains: the molecular teeth of a microbial vampire.
    O-Brien-Simpson NM; Veith PD; Dashper SG; Reynolds EC
    Curr Protein Pept Sci; 2003 Dec; 4(6):409-26. PubMed ID: 14683427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A peptide domain on gingipain R which confers immunity against Porphyromonas gingivalis infection in mice.
    Genco CA; Odusanya BM; Potempa J; Mikolajczyk-Pawlinska J; Travis J
    Infect Immun; 1998 Sep; 66(9):4108-14. PubMed ID: 9712755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porphyromonas gulae Has Virulence and Immunological Characteristics Similar to Those of the Human Periodontal Pathogen Porphyromonas gingivalis.
    Lenzo JC; O'Brien-Simpson NM; Orth RK; Mitchell HL; Dashper SG; Reynolds EC
    Infect Immun; 2016 Sep; 84(9):2575-85. PubMed ID: 27354442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential modulation of human {beta}-defensins expression in human gingival epithelia by Porphyromonas gingivalis lipopolysaccharide with tetra- and penta-acylated lipid A structures.
    Lu Q; Darveau RP; Samaranayake LP; Wang CY; Jin L
    Innate Immun; 2009 Dec; 15(6):325-35. PubMed ID: 19675119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage-elicited osteoclastogenesis in response to bacterial stimulation requires Toll-like receptor 2-dependent tumor necrosis factor-alpha production.
    Ukai T; Yumoto H; Gibson FC; Genco CA
    Infect Immun; 2008 Feb; 76(2):812-9. PubMed ID: 17998311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of RgpA, RgpB, and Kgp proteinases in virulence of Porphyromonas gingivalis W50 in a murine lesion model.
    O'Brien-Simpson NM; Paolini RA; Hoffmann B; Slakeski N; Dashper SG; Reynolds EC
    Infect Immun; 2001 Dec; 69(12):7527-34. PubMed ID: 11705929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Porphyromonas gingivalis gingipains in platelet activation and innate immune modulation.
    Klarström Engström K; Khalaf H; Kälvegren H; Bengtsson T
    Mol Oral Microbiol; 2015 Feb; 30(1):62-73. PubMed ID: 25043711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage-specific TLR2 signaling mediates pathogen-induced TNF-dependent inflammatory oral bone loss.
    Papadopoulos G; Weinberg EO; Massari P; Gibson FC; Wetzler LM; Morgan EF; Genco CA
    J Immunol; 2013 Feb; 190(3):1148-57. PubMed ID: 23264656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.